🔎 Trials Near Me

Home › Sjogren's Syndrome › North Carolina

Sjogren's Syndrome clinical trials in North Carolina

6 studies for Sjogren's Syndrome are looking for participants at sites in North Carolina.

Cities in North Carolina

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  • On Site Clinical Solutions Llc, Charlotte
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07621809

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

  • Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 27, 2026 · NCT07404865

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  • Artiva Investigational Site Charlotte, Charlotte
  • Artiva Investigational Site Charlotte, Charlotte
  • Artiva Investigational Site Statesville, Statesville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

  • Arthritis and Osteoporosis Consultants of The Carolinas - Charlotte - 1918 Randolph Rd, Charlotte
  • Duke Early Phase Clinical Research Unit - PPDS, Durham
  • Onsite Clinical Solutions, LLC - Salisbury, Salisbury
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT06747949

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

  • Duke University, Durham
RecruitingObservational studyHealthy volunteers welcome
All ages · Women · Updated Jan 8, 2026 · NCT03276923

The Myelin Disorders Biorepository Project

  • Atrium Health Wake Forest Baptist, Winston-Salem
RecruitingObservational study
All ages · All sexes · Updated Oct 23, 2025 · NCT03047369

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.